Longboard Pharmaceuticals Appoints Life Sciences Executive Dr. Jane Tiller to Board of Directors
17. November 2021 08:30 ET
|
Longboard Pharmaceuticals, Inc.
SAN DIEGO, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for...
Longboard Pharmaceuticals Announces Steven W. Spector Joins the Company as General Counsel
02. November 2021 08:30 ET
|
Longboard Pharmaceuticals, Inc.
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for...